Has Alan Terlinsky, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,053 in general payments to Alan Terlinsky, MD across 12 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Alan Terlinsky, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Alan Terlinsky, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Alan Terlinsky, MD

Nephrology · Arlington, VANPI 1225105752

Payments from drug & device makers

$1,053in general payments, 2019–2025

Across 12 payments — averaging $87.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$488
Novo Nordisk$119
Dexcom, Inc.$118
Bayer$104
Mannkind Corporation$100
Corcept Therapeutics$75
plus $48 from 1 others

What the payments were for

Food & beverage$1,03999%
Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	4	$488
Novo Nordisk	2	$119
Dexcom, Inc.	1	$118
Bayer	2	$104
Mannkind Corporation	1	$100
Corcept Therapeutics	1	$75
Boehringer Ingelheim	1	$48

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,053 in reported general payments places this provider in the 45th percentile of 298 nephrology providers in Virginia.

See all nephrology providers in Virginia →

Medicare billing

Part B allowed, 2024

$60,693

Medicare patients

Services billed

548

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
FarxigaDapagliflozin Propanediol	22	$21,615
Repatha SureclickEvolocumab	16	$17,930
Nebivolol Hcl	28	$3,146
Candesartan Cilexetil	13	$1,133
Ezetimibe	35	$841
Atorvastatin Calcium	57	$684
Tamsulosin Hcl	20	$407
Meloxicam	44	$395
Omeprazole	18	$340
Olmesartan Medoxomil	12	$312
Levothyroxine Sodium	34	$236
Indapamide	11	$159
Alprazolam	16	$132
Azithromycin	11	$129
Rosuvastatin Calcium	13	$102

Paid to pharmacies, not to this prescriber.

Other nephrology in Arlington

Olayiwola AyodejiHampton$7M
Kiranjit DhillonNorfolk$4.5M
Gaurav GuptaRichmond$2.1M
Csaba KovesdySalem$1.5M
Ramon MendezWoodbridge$1.5M
Varagur Bala SubramanianAlexandria$957K
Ahmadshah MirkhelFairfax$902K
Renuka SothinathanFairfax$617K
Steven LewinskiChesapeake$512K
Devasmita DevSalem$494K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →